Breast Cancer Trial

Screening Mammography

Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

Study EA1151 (known as TMIST) is a breast cancer screening trial of nearly 165,000 healthy women. For more information, visit the TMIST Home Page.

 

 

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

  • Physician Fact Sheet: schema, study objectives, eligibility criteria, and other key information about the study.
  • Site FAQs: questions and answers for staff at participating mammography clinics about the protocol document, recruitment, imaging, screening, and funding.
  • Site Letter to a Referring Physician: template letter to introduce a referring physician to the trial, provide site-specific information and procedures, and encourage him or her to discuss the trial with patients.
  • Site Process Summary: schema, objectives, and details about how your site can participate. [In Revision]

Recruitment and Retention Material

Participating mammography clinics (sites) should note that the National Cancer Institute’s Central Institutional Review Board (CIRB) has approved the material listed below. For sites utilizing local IRBs, please submit this in accordance with your local IRB policies prior to use.

Information and Assistance from the National Cancer Institute

  • Locations and other information 
  • Trained information specialists at the NCI are available to answer cancer-related questions from patients, family members or friends, health care providers, and researchers. Visit the NCI’s Cancer Information Service webpage for contact instructions, including telephone, live chat, email, and mail.

ClinicalTrials.gov ID: NCT03233191

 Return to TMIST Home PageReview Other Active Trials